Liver protection in the perioperative setting

Best Practice and Research: Clinical Anaesthesiology

Volumn 22, Issue 1, 2008, Pages 209-224

  Picker, O ^a   Beck, C ^a   Pannen, B ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

anaesthesia; catecholamine; hepatotoxicity; liver; perioperative; preconditioning; protection; volatile

Indexed keywords

ADRENALIN; ANESTHETIC AGENT; ANGIOTENSIN II; DESFLURANE; DOBUTAMINE; DOPAMINE; DOPEXAMINE; ELECTROLYTE; ENFLURANE; ENOXIMONE; HALOTHANE; HYPERTENSIVE FACTOR; INHALATION ANESTHETIC AGENT; ISOFLURANE; LEVOSIMENDAN; LIDOCAINE; LOPRINONE; NORADRENALIN; PHENYLEPHRINE; PHOSPHODIESTERASE INHIBITOR; SEVOFLURANE; VASOACTIVE AGENT; VASOCONSTRICTOR AGENT; VASOPRESSIN; VITAMIN K GROUP;

AUTOIMMUNE HEPATITIS; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; CARDIOVASCULAR FUNCTION; CHRONIC LIVER DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; DRUG FATALITY; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; DRUG TRANSFORMATION; GENERAL ANESTHESIA; HEART ARRHYTHMIA; HEMODYNAMICS; HEPATOPULMONARY SYNDROME; HEPATORENAL SYNDROME; HIGH RISK PATIENT; HUMAN; INCIDENCE; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FUNCTION; LIVER INJURY; LIVER PERFUSION; LIVER PROTECTION; LIVER TOXICITY; LUNG FUNCTION; NONHUMAN; OXYGENATION; PERIOPERATIVE PERIOD; PEROPERATIVE CARE; PNEUMONIA; PORTOPULMONARY HYPERTENSION; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PULMONARY VASCULAR DISEASE; REGIONAL ANESTHESIA; REVIEW; SEPTIC SHOCK; SUDDEN DEATH; UNSPECIFIED SIDE EFFECT;

ANESTHESIA, CONDUCTION; ANESTHETICS, INHALATION; CARDIOVASCULAR AGENTS; HEMODYNAMICS; HUMANS; INTRAOPERATIVE CARE; LIVER; LIVER DISEASES; PERIOPERATIVE CARE;

EID: 40949113528     PISSN: 15216896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpa.2007.09.003     Document Type: Review

References (100)

1. Garrison R.N., Cryer H.M., Howard D.A., et al. Clarification of risk factors for abdominal operations in patients with hepatic cirrhosis. Annals of Surgery 199 6 (1984) 648-655
2. United Network for Organ Sharing. UNOS 2000 Annual Report of the Scientific Registry of Transplant Recipients and the Organ Procurement and Transplantation Network: transplant data 1989-1998. Richmond, VA: UNOS; 2001.
3. Broelsch C.E., Malago M., Testa G., et al. Living donor liver transplantation in adults: outcome in Europe. Liver Transplantation 6 Suppl. 2 (2000) S64-S65
4. Schemel W.H. Unexpected hepatic dysfunction found by multiple laboratory screening. Anesthesia & Analgesia 55 6 (1976) 810-812
5. Gujral J.S., Bucci T.J., Farhood A., et al. Mechanism of cell death during warm hepatic ischemia-reperfusion in rats: apoptosis or necrosis?. Hepatology 33 2 (2001) 397-405
6. Kurokawa T., Nonami T., Harada A., et al. Mechanism and prevention of ischemia-reperfusion injury of the liver. Seminars In Surgical Oncology 12 3 (1996) 179-182
7. Tanaka K., Mitsui K., Morimoto M., et al. Increased hepatic arterial blood flow in acute viral hepatitis: assessment by color Doppler sonography. Hepatology 18 1 (1993) 21-27
8. Maynard N.D., Bihari D.J., Dalton R.N., et al. Liver function and splanchnic ischemia in critically ill patients. Chest 111 1 (1997) 180-187
9. Pannen B.H., and Robotham J.L. The acute-phase response. New Horizons (Baltimore, Md.) 3 2 (1995) 183-197
10. Jarrar D., Chaudry I.H., and Wang P. Organ dysfunction following hemorrhage and sepsis: mechanisms and therapeutic approaches. International Journal of Molecular Medicine 4 6 (1999) 575-583
11. del Olmo J.A., Flor-Lorente B., Flor-Civera B., et al. Risk factors for nonhepatic surgery in patients with cirrhosis. World Journal of Surgery 27 6 (2003) 647-652
12. Murray J.F., Dawson A.M., and Sherlock S. Circulatory changes in chronic liver disease. American Journal of Medicine 24 3 (1958) 358-367
13. Moller S., and Henriksen J.H. Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease. Heart 87 1 (2002) 9-15
14. Ma Z., and Lee S.S. Cirrhotic cardiomyopathy: getting to the heart of the matter. Hepatology 24 2 (1996) 451-459
15. Gerbes A.L., Remien J., Jungst D., et al. Evidence for down-regulation of beta-2-adrenoceptors in cirrhotic patients with severe ascites. Lancet 1 8495 (1986) 1409-1411
16. Polio J., Sieber C.C., Lerner E., et al. Cardiovascular hyporesponsiveness to norepinephrine, propranolol and nitroglycerin in portal-hypertensive and aged rats. Hepatology 18 1 (1993) 128-136
17. Castro A., Jimenez W., Claria J., et al. Impaired responsiveness to angiotensin II in experimental cirrhosis: role of nitric oxide. Hepatology 18 2 (1993) 367-372
18. Bernardi M., Calandra S., Colantoni A., et al. Q-T interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors. Hepatology 27 1 (1998) 28-34
19. Rodriguez-Roisin R., Krowka M.J., Herve P., et al. Pulmonary-hepatic vascular disorders (PHD). European Respiratory Journal 24 5 (2004) 861-880
20. Fallon M.B., and Abrams G.A. Hepatopulmonary syndrome. Current Gastroenterology Reports 2 1 (2000) 40-45
21. Barst R.J., McGoon M., Torbicki A., et al. Diagnosis and differential assessment of pulmonary arterial hypertension. Journal of the American College of Cardiology 43 12 Suppl. S (2004) 40S-47S
22. Brussino L., Bucca C., Morello M., et al. Effect on dyspnoea and hypoxaemia of inhaled N(G)-nitro-L-arginine methyl ester in hepatopulmonary syndrome. Lancet 362 9377 (2003) 43-44
23. Rodriguez-Roisin R., Agusti A.G., and Roca J. The hepatopulmonary syndrome: new name, old complexities. Thorax 47 11 (1992) 897-902
24. Mazzeo A.T., Lucanto T., and Santamaria L.B. Hepatopulmonary syndrome: a concern for the anesthetist? Pre-operative evaluation of hypoxemic patients with liver disease. Acta Anaesthesiologica Scandinavica 48 2 (2004) 178-186
25. Papper S., Belsky J.L., and Bleifer K.H. Renal failure in Laennec's cirrhosis of the liver. I. Description of clinical and laboratory features. Annals of Internal Medicine 51 (1959) 759-773
26. Gines P., Guevara M., Arroyo V., et al. Hepatorenal syndrome. Lancet 362 9398 (2003) 1819-1827
27. Keegan M.T., and Plevak D.J. Preoperative assessment of the patient with liver disease. American Journal of Gastroenterology 100 9 (2005) 2116-2127
28. Estol C.J., Faris A.A., Martinez A.J., et al. Central pontine myelinolysis after liver transplantation. Neurology 39 4 (1989) 493-498
29. Toghill P.J., Green S., and Ferguson F. Platelet dynamics in chronic liver disease with special reference to the role of the spleen. Journal of Clinical Pathology 30 4 (1977) 367-371
30. Gazzaniga G.M., Cappato S., Belli F.E., et al. Assessment of hepatic reserve for the indication of hepatic resection: how I do it. Journal of Hepato-Biliary-Pancreatic Surgery 12 1 (2005) 27-30
31. Child C.G., and Turcotte J.G. Surgery and portal hypertension. Major Problems in Clinical Surgery 1 (1964) 1-85
32. Ziser A., Plevak D.J., Wiesner R.H., et al. Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Anesthesiology 90 1 (1999) 42-53
33. Pannen B.H. New insights into the regulation of hepatic blood flow after ischemia and reperfusion. Anesthesia & Analgesia 94 6 (2002) 1448-1457
34. Brienza N., Ayuse T., O'Donnell C.P., et al. Regional control of venous return: liver blood flow. American Journal of Respiratory and Critical Care Medicine 152 2 (1995) 511-518
35. Brienza N., Revelly J.P., Ayuse T., et al. Effects of PEEP on liver arterial and venous blood flows. American Journal of Respiratory and Critical Care Medicine 152 2 (1995) 504-510
36. Hofmann D., Thuemer O., Schelenz C., et al. Increasing cardiac output by fluid loading: effects on indocyanine green plasma disappearance rate and splanchnic microcirculation. Acta Anaesthesiologica Scandinavica 49 9 (2005) 1280-1286
37. Sakka S.G., Reinhart K., and Meier-Hellmann A. Does the optimization of cardiac output by fluid loading increase splanchnic blood flow?. British Journal of Anaesthesia 86 5 (2001) 657-662
38. Lautt W.W. Mechanism and role of intrinsic regulation of hepatic arterial blood flow: hepatic arterial buffer response. American Journal of Physiology 249 5 Pt 1 (1985) G549-G556
39. Lautt W.W., Legare D.J., and d'Almeida M.S. Adenosine as putative regulator of hepatic arterial flow (the buffer response). American Journal of Physiology 248 3 Pt 2 (1985) H331-H338
40. Furchgott R.F., and Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288 5789 (1980) 373-376
41. Palmer R.M., Ferrige A.G., and Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327 6122 (1987) 524-526
42. Yanagisawa M., Kurihara H., Kimura S., et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332 6163 (1988) 411-415
43. Furchgott R.F., and Jothianandan D. Endothelium-dependent and -independent vasodilation involving cyclic GMP: relaxation induced by nitric oxide, carbon monoxide and light. Blood Vessels 28 1-3 (1991) 52-61
44. Batchelder B.M., and Cooperman L.H. Effects of anesthetics on splanchnic circulation and metabolism. The Surgical Clinics of North America 55 4 (1975) 787-794
45. Friedman L.S. The risk of surgery in patients with liver disease. Hepatology 29 6 (1999) 1617-1623
46. Gut J. Molecular basis of halothane hepatitis. Archives of Toxicology Supplement 20 (1998) 3-17
47. Vergani D., Mieli-Vergani G., Alberti A., et al. Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis. The New England Journal of Medicine 303 2 (1980) 66-71
48. Farrell G., Prendergast D., and Murray M. Halothane hepatitis. Detection of a constitutional susceptibility factor. The New England Journal of Medicine 313 21 (1985) 1310-1314
49. Lewis J.H., Zimmerman H.J., Ishak K.G., et al. Enflurane hepatotoxicity. A clinicopathologic study of 24 cases. Annals of Internal Medicine 98 6 (1983) 984-992
50. Eger II E.I., Smuckler E.A., Ferrell L.D., et al. Is enflurane hepatotoxic?. Anesthesia & Analgesia 65 1 (1986) 21-30
51. Elliott R.H., and Strunin L. Hepatotoxicity of volatile anaesthetics. British Journal of Anaesthesia 70 3 (1993) 339-348
52. Christ D.D., Kenna J.G., Kammerer W., et al. Enflurane metabolism produces covalently bound liver adducts recognized by antibodies from patients with halothane hepatitis. Anesthesiology 69 6 (1988) 833-838
53. Sinha A., Clatch R.J., Stuck G., et al. Isoflurane hepatotoxicity: a case report and review of the literature. American Journal of Gastroenterology 91 11 (1996) 2406-2409
54. Brunt E.M., White H., Marsh J.W., et al. Fulminant hepatic failure after repeated exposure to isoflurane anesthesia: a case report. Hepatology 13 6 (1991) 1017-1021
55. Webster J.A. Acute hepatitis after isoflurane anesthesia. Canadian Medical Association Journal 135 12 (1986) 1343-1344
56. Gunza J.T., and Pashayan A.G. Postoperative elevation of serum transaminases following isoflurane anesthesia. Journal of Clinical Anesthesia 4 4 (1992) 336-341
57. Turner G.B., O'Rourke D., Scott G.O., et al. Fatal hepatotoxicity after re-exposure to isoflurane: a case report and review of the literature. European Journal of Gastroenterology & Hepatology 12 8 (2000) 955-959
58. Gatecel C., Losser M.R., and Payen D. The postoperative effects of halothane versus isoflurane on hepatic artery and portal vein blood flow in humans. Anesthesia & Analgesia 96 3 (2003) 740-745
59. Tenhunen R., Marver H.S., and Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proceedings of the National Academy of Sciences of the United States of America 61 2 (1968) 748-755
60. Hoetzel A., Geiger S., Loop T., et al. Differential effects of volatile anesthetics on hepatic heme oxygenase-1 expression in the rat. Anesthesiology 97 5 (2002) 1318-1321
61. Kharasch E.D. Biotransformation of sevoflurane. Anesthesia & Analgesia 81 6 Suppl (1995) S27-S38
62. Kanaya N., Nakayama M., Fujita S., et al. Comparison of the effects of sevoflurane, isoflurane and halothane on indocyanine green clearance. British Journal of Anaesthesia 74 2 (1995) 164-167
63. O'Riordan J., O'Beirne H.A., Young Y., et al. Effects of desflurane and isoflurane on splanchnic microcirculation during major surgery. British Journal of Anaesthesia 78 1 (1997) 95-96
64. Tung D., Yoshida E.M., Wang C.S., et al. Severe desflurane hepatotoxicity after colon surgery in an elderly patient. Canadian Journal of Anaesthesia 52 2 (2005) 133-136
65. Brown Jr. B.R. Hepatotoxicity and inhalation anesthetics: views in the era of isoflurane. Journal of Clinical Anesthesia 1 5 (1989) 368-376
66. Njoku D., Laster M.J., Gong D.H., et al. Biotransformation of halothane, enflurane, isoflurane, and desflurane to trifluoroacetylated liver proteins: association between protein acylation and hepatic injury. Anesthesia & Analgesia 84 1 (1997) 173-178
67. Chase R.E., Holaday D.A., Fiserova-Bergerova V., et al. The biotransformation of ethrane in man. Anesthesiology 35 3 (1971) 262-267
68. Holaday D.A., Fiserova-Bergerova V., Latto I.P., et al. Resistance of isoflurane to biotransformation in man. Anesthesiology 43 3 (1975) 325-332
69. Sutton T.S., Koblin D.D., Gruenke L.D., et al. Fluoride metabolites after prolonged exposure of volunteers and patients to desflurane. Anesthesia & Analgesia 73 2 (1991) 180-185
70. Darling J.R., Murray J.M., Hainsworth A.M., et al. The effect of isoflurane or spinal anesthesia on indocyanine green disappearance rate in the elderly. Anesthesia & Analgesia 78 4 (1994) 706-709
71. Frink Jr. E.J., Morgan S.E., Coetzee A., et al. The effects of sevoflurane, halothane, enflurane, and isoflurane on hepatic blood flow and oxygenation in chronically instrumented greyhound dogs. Anesthesiology 76 1 (1992) 85-90
72. Hiltebrand L.B., Krejci V., Banic A., et al. Dynamic study of the distribution of microcirculatory blood flow in multiple splanchnic organs in septic shock. Critical Care Medicine 28 9 (2000) 3233-3241
73. Melendez J.A., Arslan V., Fischer M.E., et al. Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction. Journal of the American College of Surgeons 187 6 (1998) 620-625
74. Krejci V., Hiltebrand L.B., and Sigurdsson G.H. Effects of epinephrine, norepinephrine, and phenylephrine on microcirculatory blood flow in the gastrointestinal tract in sepsis. Critical Care Medicine 34 5 (2006) 1456-1463
75. De Backer D., Creteur J., Silva E., et al. Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best?. Critical Care Medicine 31 6 (2003) 1659-1667
76. Hiltebrand L.B., Krejci V., and Sigurdsson G.H. Effects of dopamine, dobutamine, and dopexamine on microcirculatory blood flow in the gastrointestinal tract during sepsis and anesthesia. Anesthesiology 100 5 (2004) 1188-1197
77. Takala J., Meier-Hellmann A., Eddleston J., et al. Effect of dopexamine on outcome after major abdominal surgery: a prospective, randomized, controlled multicenter study. European Multicenter Study Group on Dopexamine in Major Abdominal Surgery. Critical Care Medicine 28 10 (2000) 3417-3423
78. Meier-Hellmann A., Bredle D.L., Specht M., et al. Dopexamine increases splanchnic blood flow but decreases gastric mucosal pH in severe septic patients treated with dobutamine. Critical Care Medicine 27 10 (1999) 2166-2171
79. Neviere R., Mathieu D., Chagnon J.L., et al. The contrasting effects of dobutamine and dopamine on gastric mucosal perfusion in septic patients. American Journal of Respiratory and Critical Care Medicine 154 6 Pt 1 (1996) 1684-1688
80. Marik P.E., and Mohedin M. The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. The Journal of the American Medical Association 272 17 (1994) 1354-1357
81. Meier-Hellmann A., Bredle D.L., Specht M., et al. The effects of low-dose dopamine on splanchnic blood flow and oxygen uptake in patients with septic shock. Intensive Care Medicine 23 1 (1997) 31-37
82. Meier-Hellmann A., Reinhart K., Bredle D.L., et al. Epinephrine impairs splanchnic perfusion in septic shock. Critical Care Medicine 25 3 (1997) 399-404
83. Reinelt H., Radermacher P., Fischer G., et al. Effects of a dobutamine-induced increase in splanchnic blood flow on hepatic metabolic activity in patients with septic shock. Anesthesiology 86 4 (1997) 818-824
84. Westphal M., Freise H., Kehrel B.E., et al. Arginine vasopressin compromises gut mucosal microcirculation in septic rats. Critical Care Medicine 32 1 (2004) 194-200
85. Klinzing S., Simon M., Reinhart K., et al. High-dose vasopressin is not superior to norepinephrine in septic shock. Critical Care Medicine 31 11 (2003) 2646-2650
86. Kern H., Schroder T., Kaulfuss M., et al. Enoximone in contrast to dobutamine improves hepatosplanchnic function in fluid-optimized septic shock patients. Critical Care Medicine 29 8 (2001) 1519-1525
87. Kuniyoshi T., Kakihana Y., Isowaki S., et al. Effects of olprinone on hepatosplanchnic circulation and mitochondrial oxidation in a porcine model of endotoxemia. Journal of Anesthesia 19 4 (2005) 295-301
88. Pagel P.S., Hettrick D.A., and Warltier D.C. Influence of levosimendan, pimobendan, and milrinone on the regional distribution of cardiac output in anaesthetized dogs. British Journal of Pharmacology 119 3 (1996) 609-615
89. Schwarte L.A., Picker O., Bornstein S.R., et al. Levosimendan is superior to milrinone and dobutamine in selectively increasing microvascular gastric mucosal oxygenation in dogs. Critical Care Medicine 33 1 (2005) 135-142 [discussion 246-247]
90. Carini R., and Albano E. Recent insights on the mechanisms of liver preconditioning. Gastroenterology 125 5 (2003) 1480-1491
91. Azoulay D., Lucidi V., Andreani P., et al. Ischemic preconditioning for major liver resection under vascular exclusion of the liver preserving the caval flow: a randomized prospective study. Journal of the American College of Surgeons 202 2 (2006) 203-211
92. Capussotti L., Muratore A., Ferrero A., et al. Randomized clinical trial of liver resection with and without hepatic pedicle clamping. British Journal of Surgery 93 6 (2006) 685-689
93. Clavien P.A., Selzner M., Rudiger H.A., et al. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Annals of Surgery 238 6 (2003) 843-850 [discussion 851-852]
94. Man K., Fan S.T., Ng I.O., et al. Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study. Annals of Surgery 226 6 (1997) 704-711 [discussion 711-713]
95. Clavien P.A., Yadav S., Sindram D., et al. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Annals of Surgery 232 2 (2000) 155-162
96. Belghiti J., Hiramatsu K., Benoist S., et al. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. Journal of the American College of Surgeons 191 1 (2000) 38-46
97. Lentschener C., and Ozier Y. Anaesthesia for elective liver resection: some points should be revisited. European Journal of Anaesthesiology 19 11 (2002) 780-788
98. Thasler W.E., Bein T., and Jauch K.W. Perioperative effects of hepatic resection surgery on hemodynamics, pulmonary fluid balance, and indocyanine green clearance. Langenbeck's Archives of Surgery 387 7-8 (2002) 271-275
99. Pannen B.H., Kohler N., Hole B., et al. Protective role of endogenous carbon monoxide in hepatic microcirculatory dysfunction after hemorrhagic shock in rats. The Journal of Clinical Investigation 102 6 (1998) 1220-1228
100. Schmidt R., Tritschler E., Hoetzel A., et al. Heme oxygenase-1 induction by the clinically used anesthetic isoflurane protects rat livers from ischemia/reperfusion injury. Annals of Surgery 245 6 (2007) 931-942